[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343042-105":59,"doc-detail-343042-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oip5-as1-enhances-the-malignant-characteristics-and-resistance-to-chemotherapy-of-pancreatic-cancer-cells-by-targeting-mir-30d-5pmarch8","OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8","","MARCH8, an E3 ubiquitin ligase, regulates cellular processes and contributes to pancreatic cancer progression. Pancreatic cancer tissues show decreased miRNA-30d-5p and increased OIP5-AS1 and MARCH8 versus adjacent normal tissues confirmed by qRT-PCR and Western blotting. Dual-luciferase assays validate OIP5-AS1 binding to miRNA-30d-5p and miRNA-30d-5p targeting MARCH8 in PACN-1 cells. OIP5-AS1 suppresses apoptosis while promoting proliferation, invasion, and migration through the miRNA-30d-5p/MARCH8 axis in vitro, and enhances tumor growth in nude mice in vivo. OIP5-AS1 activates JAK-STAT downstream genes (IFNAR2, SOCS3, JAK1) and increases IC50 for doxorubicin, gemcitabine, and cisplatin, indicating aggressive phenotypes and chemotherapy resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oip5-as1-enhances-the-malignant-characteristics-and-resistance-to-chemotherapy-of-pancreatic-cancer-cells-by-targeting-mir-30d-5pmarch8/343042/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oip5-as1-enhances-the-malignant-characteristics-and-resistance-to-chemotherapy-of-pancreatic-cancer-cells-by-targeting-mir-30d-5pmarch8/343042.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What relationship among OIP5-AS1, miR-30d-5p, and MARCH8 is demonstrated?","Question",{"text":112,"@type":113},"Dual-luciferase reporter assays show binding between OIP5-AS1 and miR-30d-5p, and between miR-30d-5p and MARCH8 in PACN-1 cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does OIP5-AS1 affect pancreatic cancer cell behavior?",{"text":117,"@type":113},"OIP5-AS1 inhibits apoptosis and promotes cell proliferation, invasion, and migration in PACN-1 cells via the miRNA-30d-5p/MARCH8 axis in vitro.",{"name":119,"@type":110,"acceptedAnswer":120},"Does OIP5-AS1 influence chemotherapy response in pancreatic cancer cells?",{"text":121,"@type":113},"Yes. OIP5-AS1 increases IC50 values for doxorubicin, gemcitabine, and cisplatin in PACN-1 cells, indicating enhanced resistance to chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343042,1790193200,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Heliyon 10 (2024) e33835  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/ MARCH8\u003Cbr>Leilei Yinga, b, 1 , Kening Lia, b, 1 , Chao Chena, b , Ying Wang a, b , Qing Zhao a, b , Yaohui Wang a, b , Lichao Xua, b , Haozhe Huang a, b , Ge Song a, b, Wentao Lia, b , Xinhong He a, b, *\u003Cbr>a Department of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: OIP5-AS1\u003Cbr>Chemoresistance\u003Cbr>Pancreatic cancer miR-30d-5p MARCH8 |  | MARCH8, an E3 ubiquitin ligase, plays a crucial role in regulating various cellular processes such as protein degradation and signaling pathways and is implicated in the development and spread of pancreatic cancer. Analysis of pancreatic cancer tissues compared to adjacent normal tissues showed a decrease in miRNA-30d-5p levels and an increase in OIP5-AS1 and MARCH8 levels, as confirmed by qRT-PCR and Western blot analysis. The dual-luciferase reporter assay demonstrated a binding relationship between OIP5-AS1 and miRNA-30d-5p, as well as between miRNA- 30d-5p and MARCH8 in PACN-1 cells, derived from a human pancreatic carcinoma specimen. Further investigations utilizing various assays revealed that OIP5-AS1 inhibited apoptosis and promoted cell proliferation, invasion, and migration in PACN-1 cells via the miRNA-30d-5p/ MARCH8 axis in vitro. Tumor experiments in nude mice confirmed that OIP5-AS1 enhanced PACN-1 cell growth in vivo through the miRNA-30d-5p/MARCH8 axis. Additionally, OIP5-AS1 was found to activate downstream genes of the JAK-STAT pathway, namely IFNAR2, SOCS3, and JAK1, in PACN-1 cells. Furthermore, OIP5-AS1 increased the IC50 values for doxorubicin, gemcitabine, and cisplatin in PACN-1 cells, as determined by the Cell Counting Kit-8 assay. Overall, OIP5-AS1 was shown to promote aggressive traits and resistance to chemotherapy in PACN-1 cells through the miRNA-30d-5p/MARCH8 axis. |\n\n1. Introduction  \nPancreatic cancer is highly aggressive, with a generally poor prognosis due to its progressive development [1]. However, the risk factors for pancreatic cancer are sporadic, with no standard identifiable factors [2]. Therefore, early identification of pancreatic cancer  \n* Corresponding author. Department of Interventional Radiology, Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai, 200032, China.  \nE-mail addresses: [22211230004@m.fudan.edu.cn](22211230004@m.fudan.edu.cn) (L. Ying), [23211230003@m.fudan.edu.cn](23211230003@m.fudan.edu.cn) (K. Li), [chaochen_cc@fudan.edu.cn](chaochen_cc@fudan.edu.cn) (C. Chen),  \n[wangying198508@126.com](wangying198508@126.com) (Y. Wang), [zhaoqing-abcd@163.com](zhaoqing-abcd@163.com) (Q. Zhao), [wangyaohui07@126.com](wangyaohui07@126.com) (Y. Wang), [lichaoxu163@163.com](lichaoxu163@163.com)  \n(L. Xu), [hhzfudan2012@126.com](hhzfudan2012@126.com) (H. Huang), [405991541@qq.com](405991541@qq.com) (G. Song), [wentaoli@fudan.edu.cn](wentaoli@fudan.edu.cn) (W. Li), [xinhong.he@shca.org.cn](xinhong.he@shca.org.cn) (X. He).  \n1 These authors contributed equally to this work.  \n[https://doi.org/10.1016/j.heliyon.2024.e33835](https://doi.org/10.1016/j.heliyon.2024.e33835)  \nReceived 3 April 2024; Received in revised form 26 June 2024; Accepted 27 June 2024 Available online 28 June 2024  \n2405-8440/© 2024 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license  \n([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nis crucial. Membrane-associated ring finger (C3HC4) 8 (MARCH8) is the first mamma","cbCaimjtYpIgUyDo","https://ap.wps.com/l/cbCaimjtYpIgUyDo","pdf",7086340,11,"English","# Introduction\n## Pancreatic cancer aggressiveness and prognosis\n## MARCH8 in cancer biology\n## miRNA-30d-5p regulation and targets\n## OIP5-AS1 as a potential lncRNA target","[{\"question\":\"What relationship among OIP5-AS1, miR-30d-5p, and MARCH8 is demonstrated?\",\"answer\":\"Dual-luciferase reporter assays show binding between OIP5-AS1 and miR-30d-5p, and between miR-30d-5p and MARCH8 in PACN-1 cells.\"},{\"question\":\"How does OIP5-AS1 affect pancreatic cancer cell behavior?\",\"answer\":\"OIP5-AS1 inhibits apoptosis and promotes cell proliferation, invasion, and migration in PACN-1 cells via the miRNA-30d-5p/MARCH8 axis in vitro.\"},{\"question\":\"Does OIP5-AS1 influence chemotherapy response in pancreatic cancer cells?\",\"answer\":\"Yes. OIP5-AS1 increases IC50 values for doxorubicin, gemcitabine, and cisplatin in PACN-1 cells, indicating enhanced resistance to chemotherapy.\"}]","OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8 | PDF",1790049571,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87094016ae69b08a4feb055b8ce8fc80.webp",983,1341,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96127e0cf77db57f777a7964b2484e4d.webp",982,1340,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f77b7cd73d872ec5ac6790ed8e47700.webp",981,1338,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a29ccc75eacf07061ac6a20f88baf96c.webp",980,1337]